Qicai Xiao

State Key Laboratory Of Targeting Oncology, Guangxi Key Laboratory Of Biotargeting Theranostics
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

A non-enzymatic sensor based on rGO/Pt NPs/Fc-Tyr/POPD nanocomposite for hydrogen peroxide determination in liver cancer tissues.

A non-enzymatic sensor based on rGO/Pt NPs/Fc-Tyr/POPD nanocomposite for hydrogen peroxide determination in liver cancer tissues.

Journal: Mikrochimica acta

Published: May 06, 2026

Sonotheranostic nanosideromycin eradicates bacterial biofilm infections via ultrasound-detonated ROS generation and ferroptosis-like death.

Sonotheranostic nanosideromycin eradicates bacterial biofilm infections via ultrasound-detonated ROS generation and ferroptosis-like death.

Journal: Bioactive materials

Published: June 16, 2025

"Capture and kill" circulating fibrocytes by cisplatin prodrug loaded albumin disrupt the progress of pulmonary fibrosis in mice.

"Capture and kill" circulating fibrocytes by cisplatin prodrug loaded albumin disrupt the progress of pulmonary fibrosis in mice.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 12, 2025

Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies.

Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies.

Journal: Journal of advanced research

Published: June 28, 2024

Global Reactivity Profiling of the Catalytic Lysine in Human Kinome for Covalent Inhibitor Development.

Global Reactivity Profiling of the Catalytic Lysine in Human Kinome for Covalent Inhibitor Development.

Journal: Angewandte Chemie (International ed. in English)

Published: October 30, 2023

Editorial: Prodrug design and therapeutic applications.

Editorial: Prodrug design and therapeutic applications.

Journal: Frontiers in pharmacology

Published: August 19, 2023

Multitarget inhibitors/probes that target LRRK2 and AURORA A kinases noncovalently and covalently.

Multitarget inhibitors/probes that target LRRK2 and AURORA A kinases noncovalently and covalently.

Journal: Chemical communications (Cambridge, England)

Published: August 18, 2023

A New Fluorescent Probe for Hydrogen Sulfide Detection in Solution and Living Cells.

A New Fluorescent Probe for Hydrogen Sulfide Detection in Solution and Living Cells.

Journal: Molecules (Basel, Switzerland)

Published: June 12, 2023

Mesopore-encaged active MnOx in nano-silica selectively suppresses lung cancer cells by inducing autophagy.

Mesopore-encaged active MnOx in nano-silica selectively suppresses lung cancer cells by inducing autophagy.

Journal: Biomaterials science

Published: February 01, 2023

Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology.

Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology.

Journal: Frontiers in pharmacology

Published: January 04, 2023

Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications.

Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications.

Journal: Current medicinal chemistry

Published: October 30, 2022

Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy.

Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy.

Journal: Biomaterials

Published: September 17, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026